Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s wholly-owned subsidiary, Aurigene Oncology Limited, has been ordered by the GST Authority to pay a tax penalty of approximately Rs. 65 lakhs, citing errors in tax liability declarations in their annual returns. The company states that this penalty does not materially impact its financials or operations and is considering an appeal against the demand.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
